1-(3-(4-Bromo-1H-pyrazol-1-yl)phenyl)ethanone, 98%, 1g

Tapón con cono estándar de plástico, 12/21, violeta, 10 Unidad(es)

4-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHYL]-BENZOIC ACID METHYL ESTER, 1g

(S)-4-Phenyl-2-(pyridin-2-ylmethyl)-4,5-dihydrooxazole, 97%, 1g

HENEICOSANOIC ACID, 98%, 5g

2-(4-Methoxyphenyl) morpholine, 95.0%, 2.5g

2,6-Dimethylbenzoic acid, 98.0%, 5g

BOC-NH-PEG3-CH2CH2-COOH, 95.0%, 100g

Potassium ethoxide, 95.0%, 25g

[2-(1H-tetrazol-1-yl)ethyl]amine hydrochloride, 95.0%, 250mg

1-Amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid, 95.0%, 5g

(R)-3-(4-Fluoro-phenylsulfanyl)-pyrrolidine hydrochloride, 95.0%, 500mg

5-(4-Fluoro-phenyl)-[1,2,4]triazin-3-ylamine, 250mg